Health X Platform reported a consolidated net loss of ₹144.73 lakh for the financial year ended March 31, 2026, narrowing sharply from a net loss of ₹13,354.30 lakh in the previous year. The company's revenue from operations rose 18.7% to ₹1,31,926.59 lakh in FY26, compared to ₹1,11,095.46 lakh in FY25, primarily led by its Healthcare Network segment. The Board of Directors approved the audited standalone and consolidated financial results at its meeting held on May 30, 2026.

Consolidated Financial Performance

The company's total comprehensive income for the year stood at ₹73.68 lakh, a turnaround from the total comprehensive loss of ₹13,399.10 lakh reported in FY25. For the quarter ended March 31, 2026, the company reported a net loss of ₹1,296.88 lakh, compared to a net profit of ₹1,757.21 lakh in the corresponding quarter of the previous year. Revenue from operations for the quarter increased to ₹37,378.01 lakh from ₹28,584.05 lakh in the same period last year.

The statutory auditors, M/s JKVS & Co, provided an unmodified opinion on the standalone and consolidated audited financial results. The auditors highlighted a material uncertainty relating to the going concern of Genu Path Labs Limited, a step-down subsidiary, due to accumulated losses, though the financial statements were prepared on a going concern basis.

Segment and Operational Highlights

The Healthcare Network segment was the primary revenue driver, contributing ₹1,28,316.06 lakh for the year, while the Financial Services segment reported revenue of ₹1,333.64 lakh. The company, which changed its name from Sastasundar Ventures Limited during the year, operates as a Core Investment Company with a single reportable business segment within India.

Exceptional items for the year totaled a loss of ₹112.70 lakh, compared to a loss of ₹19,062.91 lakh in the previous year. These items included an impairment loss reversal of ₹10.68 lakh related to Genu Path Labs Limited and an incremental impact of ₹106.77 lakh due to new Labour Codes assessed by Sastasundar Healthbuddy Limited.

Standalone Results and Governance

On a standalone basis, the company reported a net loss of ₹95.12 lakh for FY26, widening from a net loss of ₹71.37 lakh in FY25. Total income decreased to ₹75.98 lakh from ₹120.31 lakh in the previous year. The Board re-appointed M/s. Priya Gupta & Co., Chartered Accountants, as the Internal Auditor for the financial year 2026-27.

Key Financial Metrics (Consolidated)

Health X Platform Limited has announced that its board of directors will meet on Saturday, May 30, 2026. The primary agenda of the meeting is to consider and approve the audited standalone and consolidated financial results of the company for the quarter and financial year ended March 31, 2026.

The meeting is being convened pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The board will review the performance of the company for the fourth quarter of the fiscal year 2026 and the full fiscal year.

In a disclosure related to the upcoming results, the company informed that the trading window for dealing in the securities of the company shall remain closed. This closure is effective until 48 hours after the declaration of the financial results to the stock exchanges, continuing from the previous closure notice dated March 25, 2026.

Key Meeting Details

The company, formerly known as Sastasundar Ventures Limited, has its registered office at Azimganj House, 2nd Floor, 7, Abanindra Nath Thakur Sarani, Kolkata. The intimation was signed by Pratap Singh, Company Secretary and Compliance Officer.